{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:24Z","timestamp":1780426884885,"version":"3.54.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    This study aimed to evaluate the association between noninvasive liver fibrosis and steatosis scores (including the aspartate transaminase to alanine transaminase ratio to platelet ratio index, aspartate transaminase-platelet ratio index [APRI], Fibrosis-4 index, modified Fibrosis-4 index [mFIB-4], and hepatic steatosis index) as well as ultrasonographic steatosis scores (USS), with histopathological features of endometrioid-type endometrial cancer (EC) and their potential impact on survival outcomes. This retrospective observational study included 415 patients diagnosed with endometrioid-type EC who underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy. Preoperative metabolic scores, including aspartate transaminase to alanine transaminase ratio to platelet ratio index, APRI, Fibrosis-4 index, mFIB-4, and hepatic steatosis index, were calculated from blood samples. USS and the diagnosis of metabolic dysfunction-associated fatty liver disease were based on liver imaging and metabolic criteria. Disease-free survival and overall survival were analyzed; significance was set at\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05. Analysis showed that patients with body mass index &lt;30\u2009kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    had higher rates of deep myometrial invasion (44.8% vs 27.3%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.014), serosal invasion (6.9% vs 0.6%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.017), lympho-vascular space invasion (34.5% vs 15.8%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002), and MSH6 loss (9.8% vs 1.4%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.014) compared to obese patients. USS correlated with age, myometrial invasion depth, and PMS2 loss. Myometrial invasion &gt;1\/2 was more frequent in patients with mFIB-4\u2005&gt;\u20050.19 (37.5% vs 29%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.048). Lower APRI (\u22640.19) was related to the higher rate of cervical stromal invasion (15.8% vs 9.1%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.027), lympho-vascular space invasion (29.7% vs 17.7%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002), adnexal involvement (11.3% vs 5.6%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.026), and lymph node metastasis (24.1% vs 12.8%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.009). Multivariable analysis showed advanced stage (HR\u2005=\u20055.172,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and presence of at least one mismatch repair gene defect (HR\u2005=\u20052.936,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.011) independently predicted poor disease-free survival. Advanced stage (HR\u2005=\u20057.519,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and a high mFIB-4 score (HR\u2005=\u20052.281,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.020) independently predicted worse overall survival. In conclusion, advanced stage remains the most significant independent predictor of poor oncological outcomes in endometrioid-type EC. Furthermore, this study highlights the prognostic relevance of metabolic dysfunction in this patient group. Noninvasive liver fibrosis markers (particularly mFIB-4 and APRI) were significantly associated with adverse histopathological features and survival outcomes, suggesting their potential role in risk stratification and prognosis assessment in endometrioid-type EC.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044602","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:01:54Z","timestamp":1759248114000},"page":"e44602","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Advanced stage, elevated mFIB-4 score, and MMR gene loss as independent predictors of oncological outcomes in endometrioid endometrial cancer: A retrospective observational study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-4196","authenticated-orcid":false,"given":"Gunsu","family":"Kimyon Comert","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2405-7567","authenticated-orcid":false,"given":"Neslihan","family":"Bayramoglu","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1747-4312","authenticated-orcid":false,"given":"\u0130rem","family":"Kar","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Ankara University, Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-7457","authenticated-orcid":false,"given":"Eda","family":"Kayali","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliha","family":"Firat Cuylan","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1803-7506","authenticated-orcid":false,"given":"Emel","family":"\u00c7evikkan","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-781X","authenticated-orcid":false,"given":"Derya","family":"Ari","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-2542","authenticated-orcid":false,"given":"Meral","family":"Akdogan Kayhan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-1143","authenticated-orcid":false,"given":"Taner","family":"Turan","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1055\/a-1124-7139","article-title":"Obesity in gynecologic oncology.","volume":"80","author":"K\u00f6lbl","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity.","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-63657-8_1","article-title":"The definition and prevalence of obesity and metabolic syndrome: correlative clinical evaluation based on phenotypes.","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/medicina61040664","article-title":"New frontiers in nutritional and therapeutic interventions for obesity phenotypes.","volume":"61","author":"Patti","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10555-022-10046-2","article-title":"Obesity: a perfect storm for carcinogenesis.","volume":"41","author":"Harris","year":"2022","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl 1","key":"R8-20260602","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijgo.13870","article-title":"Obesity and gynecological cancers: a toxic relationship.","volume":"155","author":"Wichmann","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/oby.23444","article-title":"Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome.","volume":"30","author":"Karra","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/jcm14030751","article-title":"The association between metabolic syndrome and the risk of endometrial cancer in pre- and post-menopausal women: a UK Biobank study.","volume":"14","author":"Karkia","year":"2025","journal-title":"J Clin Med"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"04155","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynaecological cancers in 2022 and projections to 2050.","volume":"14","author":"Zhu","year":"2024","journal-title":"J Glob Health"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer: 2023.","volume":"34","author":"Berek","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"17793","DOI":"10.1038\/s41598-023-44243-y","article-title":"AST\/ALT-to-platelet ratio (AARPRI) predicts gynaecological cancers: a 8-years follow-up study in 653 women.","volume":"13","author":"Crudele","year":"2023","journal-title":"Sci Rep"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3390\/curroncol30040287","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with cervical stromal involvement in endometrial cancer patients: a cross-sectional study in South China.","volume":"30","author":"Lin","year":"2023","journal-title":"Curr Oncol"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00432-024-05708-3","article-title":"Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma.","volume":"150","author":"Schrecker","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive scores and serum biomarkers for fatty liver in the era of metabolic dysfunction-associated steatotic liver disease (MASLD): a comprehensive review from NAFLD to MAFLD and MASLD.","volume":"13","author":"Abdelhameed","year":"2024","journal-title":"Curr Obes Rep"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"e0202393","DOI":"10.1371\/journal.pone.0202393","article-title":"Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.","volume":"13","author":"Peleg","year":"2018","journal-title":"PLoS One"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"Pt B","key":"R19-20260602","first-page":"2985","article-title":"AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the obesity society.","volume":"63","author":"Jensen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaging.2012.12.006","article-title":"Relationship goals of middle-aged, young-old, and old-old internet daters: an analysis of online personal ads.","volume":"27","author":"Alterovitz","year":"2013","journal-title":"J Aging Stud"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2024.02.002","article-title":"2023 FIGO staging system for endometrial cancer: the evolution of the revolution.","volume":"184","author":"Gaffney","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease.","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers13112623","article-title":"New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP guidelines.","volume":"13","author":"Santoro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s13668-022-00447-8","article-title":"The association between nutrition, obesity, inflammation, and endometrial cancer: a scoping review.","volume":"12","author":"Thrastardottir","year":"2023","journal-title":"Curr Nutr Rep"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.7150\/ijms.60780","article-title":"Relationship between the metabolic associated fatty liver disease and endometrial thickness in postmenopausal women: a cross-sectional study in China.","volume":"18","author":"Wei","year":"2021","journal-title":"Int J Med Sci"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity \u2013 a longitudinal cohort study.","volume":"71","author":"Allen","year":"2019","journal-title":"J Hepatol"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.15195","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study.","volume":"42","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Liver Int"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate.","volume":"68","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/cancers17081322","article-title":"Increased risk of early-onset endometrial cancer in women aged 20\u201339 years with non-alcoholic fatty liver disease: a nationwide cohort study.","volume":"17","author":"Park","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/hep.31845","article-title":"Cancer risk in patients with biopsy\u2010confirmed nonalcoholic fatty liver disease: a population\u2010based cohort study.","volume":"74","author":"Simon","year":"2021","journal-title":"Hepatology"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/jgh.15350","article-title":"The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development.","volume":"36","author":"Yamamoto","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"7","DOI":"10.20517\/mtod.2023.56","article-title":"Is liver fibrosis a risk factor for gynecological cancers?","volume":"4","author":"Lonardo","year":"2024","journal-title":"Metab Target Organ Damage"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update.","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"R36-20260602","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/nu15010066","article-title":"The FIB-4 index predicts the development of liver-related events, extrahepatic cancers, and coronary vascular disease in patients with NAFLD.","volume":"15","author":"Kamada","year":"2022","journal-title":"Nutrients"},{"key":"R37-20260602","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ygyno.2019.03.258","article-title":"Association of obesity with survival in patients with endometrial cancer.","volume":"154","author":"Van Arsdale","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R38-20260602","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R39-20260602","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40364-025-00742-w","article-title":"The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy.","volume":"13","author":"Morales-Pacheco","year":"2025","journal-title":"Biomarker Res"},{"key":"R40-20260602","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yexcr.2015.04.007","article-title":"The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism.","volume":"335","author":"Conde","year":"2015","journal-title":"Exp Cell Res"},{"key":"R41-20260602","doi-asserted-by":"crossref","first-page":"1389804","DOI":"10.3389\/fonc.2024.1389804","article-title":"The AST\/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy.","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"R42-20260602","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kws434","article-title":"Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype.","volume":"177","author":"Amankwah","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R43-20260602","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2012.05.019","article-title":"Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression.","volume":"126","author":"Grzankowski","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R44-20260602","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3802\/jgo.2018.29.e39","article-title":"Endometrial cancer risk and survival by tumor MMR status.","volume":"29","author":"Nagle","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"R45-20260602","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2020.05.406","article-title":"Mismatch repair deficiency is predictive of improved response to radiation therapy in patients with advanced or recurrent endometrial cancer.","volume":"159","author":"AlHilli","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R46-20260602","doi-asserted-by":"crossref","first-page":"1147657","DOI":"10.3389\/fonc.2023.1147657","article-title":"Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer.","volume":"13","author":"Riedinger","year":"2023","journal-title":"Front Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:28Z","timestamp":1780423288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":46,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044602","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-06-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}